Literature DB >> 11145481

Complementary medicine: time for critical engagement.

.   

Abstract

Mesh：

Year:  2000        PMID： 11145481

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Is the increasing use of evidence-based pharmacotherapy causing the renaissance of complementary medicine?

Authors:  Samuel Vozeh
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

Review 2.  Research priorities in traditional Chinese medicine.

Authors:  Jin-Ling Tang
Journal:  BMJ       Date:  2006-08-19

3.  Add-On therapy with Chinese herb medicine Bo-Er-Ning capsule (BENC) improves outcomes of gastric cancer patients: a randomized clinical trial followed with bioinformatics-assisted mechanism study.

Authors:  Boyu Pan; Jingyuan Zang; Jie He; Zhen Wang; Liren Liu
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

4.  Randomized controlled trials in pediatric complementary and alternative medicine: where can they be found?

Authors:  Margaret Sampson; Kaitryn Campbell; Isola Ajiferuke; David Moher
Journal:  BMC Pediatr       Date:  2003-02-14       Impact factor: 2.125

5.  Changing academic medicine: strategies used by academic leaders of integrative medicine-a qualitative study.

Authors:  Claudia M Witt; Christine Holmberg
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-11       Impact factor: 2.629

6.  Corporate culture assessments in integrative oncology: a qualitative case study of two integrative oncology centers.

Authors:  Nadine Mittring; Marion Pérard; Claudia M Witt
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-30       Impact factor: 2.629

7.  Experts' opinions on terminology for complementary and integrative medicine - a qualitative study with leading experts.

Authors:  Christine Holmberg; Benno Brinkhaus; Claudia Witt
Journal:  BMC Complement Altern Med       Date:  2012-11-14       Impact factor: 3.659

8.  The PAV trial: does lactobacillus prevent post-antibiotic vulvovaginal candidiasis? Protocol of a randomised controlled trial [ISRCTN24141277].

Authors:  Marie Pirotta; Jane Gunn; Patty Chondros; Sonia Grover; Susan Hurley; Suzanne Garland
Journal:  BMC Fam Pract       Date:  2004-03-28       Impact factor: 2.497
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.